Supplemental Experimental Procedures
Cell lines 786-O (786-O-) and RCC4 (RCC4-) cell lines were kindly provided by B. Jimenez (Instituto de Investigaciones Biomédicas CSIC-UAM, Madrid, Spain). Cells were grown in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), 50 units/mL penicillin, 50 μg/mL streptomycin sulfate, and 2 mmol/L glutamine (all Gibco, Life technologies, California, USA).
Hypoxia and western blot analyses
786-O and RCC4-cells were maintained in normoxia at 21% O 2 , 5% CO 2 , 37ºC and in hypoxia from 786 O and RCC4 cells were maintained in normoxia at 21% O 2 , 5% CO 2 , 37 C and in hypoxia from 0,5 to 3% to O 2 , 5% CO 2 , 37ºC and full reconstituted RPMI medium (100% nutrients) or a dilution of 50% PBS (50% nutrients) from 6 until 48 hours.
Western blot analysis utilized monoclonal anti-β-actin (A5441, Sigma-Aldrich), anti-vinculin (V9131, Sigma-Aldrich), rabbit anti-MCT1 (H-70) (Santa Cruz Biotechnology, Cat. No SC-50324), rabbit anti-MCT4 (H-90) (Santa Cruz Biotechnology, Cat. No SC-50329). For western blots in Figure S2 , quantification was performed using Quantity One software (version 4.6.1; Bio-Rad). Statistical
was done using Mann-Whitney U test (2-tailed) performed in GraphPad Prism (GraphPad Software, Inc. USA). Differences were considered statistically significant at p<0.05. (*, p<0.05; **, p< 0.01; ***, p< 0.001, ****, p< 0.0001).
Glucose and lactate measurements

